Skip to main content

Vivos Therapeutics, Inc.

For the period ended Mar 31, 2026. Filed May 20, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 20, 2026

VVOS$0.09-8.7%Stored close · as of Nov 6, 2026
Opening this filing…